Summit Therapeutics on the Cusp: A Dual-Action Lung Cancer Drug Faces its Moment of Truth
Summit Therapeutics' Lung Cancer Hope Faces Fierce Competition and Scrutiny
Groundbreaking Cancer Drug Ivonescimab Propels Akeso Shares After Major Clinical Trial Success